MOTION INFORMATICS LTD

Motion Informatics Ltd specializes in transcutaneous neuromuscular electrical stimulation (TENS) systems for physical therapy. These devices are primarily designed to stimulate muscles and manage pain through electrical impulses delivered via electrodes or standalone units. Their portfolio includes both stimulating electrodes (like the STIMEL-03) and complete TENS devices.

The company is headquartered in the United States. This location influences its regulatory compliance and reporting requirements, particularly for devices marketed in the U.S. market.

Motion Informatics Ltd’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for Class II devices, which include their TENS systems and stimulating electrodes.

Motion Informatics Ltd’s devices fall under Class II classification by the FDA. This classification applies to moderate-risk devices that require special controls beyond general controls to ensure safety and effectiveness, such as TENS systems used for muscle stimulation and pain management.